JP2017529346A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529346A5
JP2017529346A5 JP2017514615A JP2017514615A JP2017529346A5 JP 2017529346 A5 JP2017529346 A5 JP 2017529346A5 JP 2017514615 A JP2017514615 A JP 2017514615A JP 2017514615 A JP2017514615 A JP 2017514615A JP 2017529346 A5 JP2017529346 A5 JP 2017529346A5
Authority
JP
Japan
Prior art keywords
pyrimidin
pharmaceutically acceptable
acceptable salt
pyrido
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017514615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017529346A (ja
JP6552608B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/050432 external-priority patent/WO2016044429A1/en
Publication of JP2017529346A publication Critical patent/JP2017529346A/ja
Publication of JP2017529346A5 publication Critical patent/JP2017529346A5/ja
Application granted granted Critical
Publication of JP6552608B2 publication Critical patent/JP6552608B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017514615A 2014-09-17 2015-09-16 ヒストンデメチラーゼ阻害剤 Expired - Fee Related JP6552608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462051691P 2014-09-17 2014-09-17
US62/051,691 2014-09-17
PCT/US2015/050432 WO2016044429A1 (en) 2014-09-17 2015-09-16 Histone demethylase inhibitors

Publications (3)

Publication Number Publication Date
JP2017529346A JP2017529346A (ja) 2017-10-05
JP2017529346A5 true JP2017529346A5 (cg-RX-API-DMAC7.html) 2018-10-25
JP6552608B2 JP6552608B2 (ja) 2019-07-31

Family

ID=55525128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017514615A Expired - Fee Related JP6552608B2 (ja) 2014-09-17 2015-09-16 ヒストンデメチラーゼ阻害剤

Country Status (17)

Country Link
US (7) US9643965B2 (cg-RX-API-DMAC7.html)
EP (2) EP3453710B1 (cg-RX-API-DMAC7.html)
JP (1) JP6552608B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170048591A (cg-RX-API-DMAC7.html)
CN (1) CN107205391A (cg-RX-API-DMAC7.html)
AU (1) AU2015317806A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017005511A2 (cg-RX-API-DMAC7.html)
CA (1) CA2961610A1 (cg-RX-API-DMAC7.html)
CL (1) CL2017000659A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017003538A2 (cg-RX-API-DMAC7.html)
EA (1) EA201790603A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP17023551A (cg-RX-API-DMAC7.html)
ES (1) ES2910226T3 (cg-RX-API-DMAC7.html)
IL (1) IL251179A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017003466A (cg-RX-API-DMAC7.html)
SG (1) SG11201702147TA (cg-RX-API-DMAC7.html)
WO (1) WO2016044429A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE034906T2 (hu) 2013-03-15 2018-03-28 Quanticel Pharmaceuticals Inc Hiszton-demetiláz inhibitorok
JP6552608B2 (ja) 2014-09-17 2019-07-31 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
WO2017161012A1 (en) 2016-03-15 2017-09-21 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6745905B2 (ja) 2016-11-28 2020-08-26 帝人ファーマ株式会社 ピリド[3,4−d]ピリミジン誘導体又はその溶媒和物の結晶
CA3056641A1 (en) 2017-03-29 2018-10-04 Purdue Research Foundation Inhibitors of kinase networks and uses thereof
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116253712B (zh) * 2023-03-27 2025-05-02 昆山市第一人民医院 5,6,7-三甲氧基-2,3-二氢喹啉类化合物、药物组合物及用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033472A1 (en) * 2001-10-17 2003-04-24 Kirin Beer Kabushiki Kaisha Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
WO2003078427A1 (en) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazines as inhibitors of protein kinases
JP2007501854A (ja) * 2003-05-27 2007-02-01 ファイザー・プロダクツ・インク 受容体型チロシンキナーゼ阻害薬としてのキナゾリン類およびピリド[3,4−d]ピリミジン類
JP2008510823A (ja) * 2004-08-23 2008-04-10 メルク エンド カムパニー インコーポレーテッド Akt活性阻害剤
FR2876103B1 (fr) 2004-10-01 2008-02-22 Aventis Pharma Sa Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
US20080221132A1 (en) 2006-09-11 2008-09-11 Xiong Cai Multi-Functional Small Molecules as Anti-Proliferative Agents
TW200922590A (en) 2007-09-10 2009-06-01 Curis Inc VEGFR inhibitors containing a zinc binding moiety
JP5552608B2 (ja) 2012-04-27 2014-07-16 株式会社ソフイア 遊技機
RS55764B1 (sr) 2012-10-02 2017-07-31 Gilead Sciences Inhibitori histonskih demetilaza
AU2013361255B2 (en) 2012-12-19 2017-01-05 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
AU2013363957B2 (en) 2012-12-21 2018-03-22 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6320506B2 (ja) 2013-03-12 2018-05-09 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
HUE034906T2 (hu) 2013-03-15 2018-03-28 Quanticel Pharmaceuticals Inc Hiszton-demetiláz inhibitorok
US20160143910A1 (en) 2013-03-15 2016-05-26 Constellation Pharmaceuticals, Inc. Methods of treating cancer and preventing cancer drug resistance
EP3738960A1 (en) 2014-06-25 2020-11-18 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
JP6552608B2 (ja) * 2014-09-17 2019-07-31 セルジーン クオンティセル リサーチ,インク. ヒストンデメチラーゼ阻害剤
US10030017B2 (en) 2014-09-17 2018-07-24 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017161012A1 (en) 2016-03-15 2017-09-21 Celgene Quanticel Research, Inc. Histone demethylase inhibitors

Similar Documents

Publication Publication Date Title
JP2017529346A5 (cg-RX-API-DMAC7.html)
JP2023027269A5 (cg-RX-API-DMAC7.html)
JP2017530962A5 (cg-RX-API-DMAC7.html)
HRP20151001T4 (hr) Sredstva kao induktori apoptoze za liječenje raka te imunih i autoimunih bolesti
RU2004117887A (ru) Ариланилиновые агонисты бета2 адренергических рецепторов
HRP20141094T1 (hr) 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
JP2010517946A5 (cg-RX-API-DMAC7.html)
HRP20200341T1 (hr) Bromodomenski (bet) inhibitori
JP2007523867A5 (cg-RX-API-DMAC7.html)
JP2008110984A5 (cg-RX-API-DMAC7.html)
JP2018507899A5 (cg-RX-API-DMAC7.html)
JP2013542937A5 (cg-RX-API-DMAC7.html)
JP2004525951A5 (cg-RX-API-DMAC7.html)
JP2013505969A5 (cg-RX-API-DMAC7.html)
JP2005509024A5 (cg-RX-API-DMAC7.html)
JP2013532727A5 (cg-RX-API-DMAC7.html)
JP2016501250A5 (cg-RX-API-DMAC7.html)
JP2010501587A5 (cg-RX-API-DMAC7.html)
JP2012255002A5 (cg-RX-API-DMAC7.html)
JP2013534245A5 (cg-RX-API-DMAC7.html)
JP2007501831A5 (cg-RX-API-DMAC7.html)
JP2018529770A5 (cg-RX-API-DMAC7.html)
JP2007519695A5 (cg-RX-API-DMAC7.html)
JP2013505949A5 (cg-RX-API-DMAC7.html)
JP2005521650A5 (cg-RX-API-DMAC7.html)